Harvard Bioscience Inc. Files Corporate Presentation (Reg FD)

What Happened Harvard Bioscience, Inc. (HBIO) filed a Form 8-K on August 11, 2026 (Item 7.01) to disclose and attach its current corporate slide presentation, which the company presents to the investment community at industry conferences. The deck is filed as Exhibit 99.1 (corporate slide presentation dated August 2026) and is incorporated by reference. The filing also lists the Interactive Data File (Exhibit 104) under Item 9.01.

Key Details

• Filing date: August 11, 2026 (Form 8-K).
• Exhibit attached: 99.1 — Corporate slide presentation of Harvard Bioscience, dated August 2026.
• Disclosure type: Item 7.01 — Regulation FD Disclosure (slides used at investor/industry conferences).
• Item 9.01 includes Exhibit 104 — Cover Page Interactive Data File (Inline XBRL).

Why It Matters This 8-K is a standard Regulation FD disclosure that makes Harvard Bioscience’s current investor presentation publicly available. It is not an earnings release and does not announce management changes, mergers, or financial results; investors should review the attached slide deck for any updated corporate strategy, product or operational highlights the company has chosen to present.